Translating Glutamate: From Pathophysiology to Treatment

Common polygenic variation contributes to risk of schizophrenia and bipolar disorder

The International Schizophrenia Consortium (2009) · Nature · doi:10.1038/nature08185 · Cited by 4,821

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879

Antidepressant effects of ketamine in depressed patients

Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.

Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766

Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans: Psychotomimetic, Perceptual, Cognitive, and Neuroendocrine Responses

Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330

Recent advances in the phencyclidine model of schizophrenia

(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904

mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA Antagonists

Li, N., Lee, B., Liu, R.-J., Banasr, M., Dwyer, J. M., Iwata, M., Li, X.-Y., Aghajanian, G., & Duman, R. S. (2010) · Science · doi:10.1126/science.1190287 · Cited by 2,881

The Neural Basis of Addiction: A Pathology of Motivation and Choice

Kalivas, P. W., & Volkow, N. D. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.8.1403 · Cited by 2,757

Drug Addiction and Its Underlying Neurobiological Basis: Neuroimaging Evidence for the Involvement of the Frontal Cortex

Goldstein, R. Z., & Volkow, N. D. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.10.1642 · Cited by 2,667

Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence

Harrison, P. J., & Weinberger, D. R. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001558 · Cited by 2,020

TAK-071, a muscarinic M1 receptor positive allosteric modulator, attenuates scopolamine-induced quantitative electroencephalogram power spectral changes in cynomolgus monkeys

Kurimoto, E., Nakashima, M., Kimura, H., & Suzuki, M. (2019) · PLoS ONE · doi:10.1371/journal.pone.0207969 · Cited by 21

Pituitary Adenylate cyclase‐activating polypeptide orchestrates neuronal regulation of the astrocytic glutamate‐releasing mechanism system xc−

Kong, L., Albano, R., Madayag, A., Raddatz, N. J., Mantsch, J. R., Choi, S., Lobner, D., & Baker, D. L. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13566 · Cited by 19

Cocaine- and Amphetamine-Regulated Transcript (CART) Peptide Plays Critical Role in Psychostimulant-Induced Depression

Qing, M., Kim, H., Oh, S., Lee, Y., Hu, Z., & Oh, K. (2018) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2018.141 · Cited by 20

Behavioral assessment of acute inhibition of system xc - in rats

Lutgen, V., Resch, J. M., Qualmann, K. J., Raddatz, N. J., Panhans, C. M., Olander, E. M., Kong, L., Choi, S., Mantsch, J. R., & Baker, D. L. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3612-4 · Cited by 21

Genome-wide gene pathway analysis of psychotic illness symptom dimensions based on a new schizophrenia-specific model of the OPCRIT

Docherty, A. R., Bigdeli, T. B., Edwards, A. C., Bacanu, S., Lee, D., Neale, M. C., Wormley, B., Walsh, D., O’Neill, F. A., Riley, B. P., et al. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.02.013 · Cited by 19

Lithium: a potential therapeutic strategy in obsessive–compulsive disorder by targeting the canonical WNT/β pathway

Vallée, A., Vallée, J.-N., & Lecarpentier, Y. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01329-3 · Cited by 18

Serotonin is a common thread linking different classes of antidepressants

Witt, C. E., Mena, S., Holmes, J., Hersey, M., Buchanan, A. M., Parke, B., Saylor, R., Honan, L. E., Berger, S. N., Lumbreras, S., et al. (2023) · Cell Chemical Biology · doi:10.1016/j.chembiol.2023.10.009 · Cited by 18

Repetitive deep TMS in alcohol dependent patients halts progression of white matter changes in early abstinence

Selim, M. K., Harel, M., Santis, S. D., Perini, I., Sommer, W. H., Heilig, M. A., Zangen, A., & Canals, S. (2023) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.13624 · Cited by 20

Investigating the role of glutathione in mismatch negativity: An insight into NMDA receptor disturbances in bipolar disorder

Chitty, K. M., Lagopoulos, J., Hickie, I. B., & Hermens, D. F. (2014) · Clinical Neurophysiology · doi:10.1016/j.clinph.2014.09.025 · Cited by 18

Network analysis of gene expression in peripheral blood identifies mTOR and NF-κB pathways involved in antipsychotic-induced extrapyramidal symptoms

Mas, S., Gassó, P., Parellada, E., Bernardo, M., & Lafuente, A. (2015) · The Pharmacogenomics Journal · doi:10.1038/tpj.2014.84 · Cited by 18

Neuromapping techniques in drug discovery: pharmacological MRI for the assessment of novel antipsychotics

Bifone, A., & Gozzi, A. (2012) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2012.724057 · Cited by 18

Effects of novel, high affinity glycine transport inhibitors on frontostriatal dopamine release in a rodent model of schizophrenia

Balla, A., Schneider, S., Sershen, H. W., & Javitt, D. C. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.03.006 · Cited by 16

Reduction in phencyclidine induced sensorimotor gating deficits in the rat following increased system xc − activity in the medial prefrontal cortex

Lutgen, V., Qualmann, K. J., Resch, J. M., Kong, L., Choi, S., & Baker, D. L. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2926-3 · Cited by 16

Imaging metabotropic glutamate receptor system: Application of positron emission tomography technology in drug development

Xu, Y., & Li, Z. (2019) · Medicinal Research Reviews · doi:10.1002/med.21566 · Cited by 15

Metabolite abnormalities in psychosis risk: A meta-analysis of proton magnetic resonance spectroscopy studies

Wang, Y.-M., Xiao, Y., & Xie, W.-L. (2020) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2020.102220 · Cited by 15

The development of compulsive coping behaviour is associated with a downregulation of Arc in a Locus Coeruleus neuronal ensemble

Velázquez-Sánchez, C., Mureşan, L., Martí‐Prats, L., & Belin, D. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-022-01522-y · Cited by 15

Advances in the study of NMDA receptors in depression pathogenesis and the antidepressant efficacy of their antagonists

Chen, M., Jin, J., Bi, H., Zhang, Y., Sun, M., Li, X., & Wang, Y. (2025) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2025.104502 · Cited by 14

Antiglutamatergic agents for obsessive-compulsive disorder: Where are we now and what are possible future prospects?

Maraone, A., Tarsitani, L., Pinucci, I., & Pasquini, M. (2021) · World Journal of Psychiatry · doi:10.5498/wjp.v11.i9.568 · Cited by 19

Ionizing radiation induces neurotoxicity in Xenopus laevis embryos through neuroactive ligand-receptor interaction pathway

Hou, Y., Shang, Y., Xu, F., Li, T., Li, M., Ling, W., Fan, S., Hou, W., Gou, W., Shang, H., et al. (2024) · Environmental Research · doi:10.1016/j.envres.2024.119237 · Cited by 14

Translational psychiatry—light at the end of the tunnel

Jones, K., Menniti, F. S., & Sivarao, D. V. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12725 · Cited by 13

WNT/β-catenin pathway and circadian rhythms in obsessive-compulsive disorder

Vallée, A., Lecarpentier, Y., & Vallée, J.-N. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.332133 · Cited by 11

The N-Methyl-D-Aspartate Receptor as a Neurobiological Intersection Between Bipolar Disorder and Alcohol Use: A Longitudinal Mismatch Negativity Study

Chitty, K. M., Lagopoulos, J., Kaur, M., Hickie, I. B., & Hermens, D. F. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu113 · Cited by 12

Long-term systemic administration of kynurenic acid brain region specifically elevates the abundance of functional CB1 receptors in rats

Zádor, F., Nagy-Grócz, G., Dvorácskó, S., Bohár, Z., Cseh, E. K., Zádori, D., Párdutz, Á., Szűcs, E., Tömböly, C., Borsodi, A. D., et al. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104752 · Cited by 12

Inflammation in Schizophrenia: The Role of Disordered Oscillatory Mechanisms

Speers, L. J., & Bilkey, D. K. (2025) · Cells · doi:10.3390/cells14090650 · Cited by 12

Lithium and Atypical Antipsychotics: The Possible WNT/β Pathway Target in Glaucoma

Vallée, A., Vallée, J.-N., & Lecarpentier, Y. (2021) · Biomedicines · doi:10.3390/biomedicines9050473 · Cited by 11

Towards Novel Potential Molecular Targets for Antidepressant and Antipsychotic Pharmacotherapies

Kositsyn, Y. M., de Abreu, M. S., Kolesnikova, T. O., Lagunin, A. A., Poroikov, V., Harutyunyan, H. S., Yenkoyan, K. B., & Kalueff, A. V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119482 · Cited by 11

Amygdala activity associated with social choice in mice

Mihara, T., Mensah-Brown, K. G., Sobota, R., Lin, R., Featherstone, R. E., & Siegel, S. J. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.04.040 · Cited by 11

Alterations in glutamatergic signaling in the brain of dopamine supersensitivity psychosis and non-supersensitivity psychosis model rats

Oda, Y., Fujita, Y., Oishi, K., Nakata, Y., Takase, M., Niitsu, T., Kanahara, N., Shirayama, Y., Hashimoto, K., & Iyo, M. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4695-5 · Cited by 11

Interaction of Background Noise and Auditory Hallucinations on Phonemic Mismatch Negativity (MMN) and P3a Processing in Schizophrenia

Francis, A. M., Knott, V., Labelle, A., & Fisher, D. J. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.540738 · Cited by 11

Effects of novel beta-lactam, MC-100093, and ceftriaxone on astrocytic glutamate transporters and neuroinflammatory factors in nucleus accumbens of C57BL/6 mice exposed to escalated doses of morphine

Sari, Y., Swiss, G. M. S., Alrashedi, F. A., Baeshen, K. A., Alshammari, S. A., AlSharari, S. D., Ali, N., Alasmari, A. F., Alhoshani, A., Alameen, A. A., et al. (2024) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2024.102108 · Cited by 10

Altered cortical synaptic lipid signaling leads to intermediate phenotypes of mental disorders

Tüscher, O., Muthuraman, M., Horstmann, J.-P., Horta, G., Radyushkin, K., Baumgart, J., Sigurdsson, T., Endle, H., Ji, H., Kuhnhäuser, P., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02598-2 · Cited by 10

Mismatch Negativity (MMN) as a Pharmacodynamic/Response Biomarker for NMDA Receptor and Excitatory/Inhibitory Imbalance-Targeted Treatments in Schizophrenia

Javitt, D. C. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-69491-2_15 · Cited by 8

Ketamine a dissociative anesthetic: Neurobiology and biomolecular exploration in depression

Liu, G.-L., Cui, Y., Lu, C., & Zhao, P. (2020) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2020.109006 · Cited by 10

N-methyl- -aspartate receptor antagonism modulates P300 event-related potentials and associated activity in salience and central executive networks

de la Salle, S., Shah, D. K., Choueiry, J., Bowers, H., McIntosh, J. F., Carroll, B., Ilivitsky, V., & Knott, V. (2021) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2021.173287 · Cited by 8

Neurotransmitter Systems: Glutamate

Olive, M. F., Powell, G. L., McClure, E. A., & Gipson, C. D. (2018) · Springer eBooks · doi:10.1007/978-981-10-5311-5_2 · Cited by 7

Harnessing N-Methyl- d -Aspartate Receptors for New Treatment Development in Psychiatry: Positive Lessons From Negative Studies

Javitt, D. C. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13040503 · Cited by 7

Unraveling the mysteries of schizophrenia: Insights into prefrontal cortex dysfunction and therapeutic implications

Cheng, B.-F., Liang, Y., & Wu, Q. (2025) · World Journal of Psychiatry · doi:10.5498/wjp.v15.i11.107604 · Cited by 7

Computational Synaptic Modeling of Pitch and Duration Mismatch Negativity in First-Episode Psychosis Reveals Selective Dysfunction of the N-Methyl-D-Aspartate Receptor

López‐Caballero, F., Auksztulewicz, R., Howard, Z. L., Rosch, R. E., Todd, J., & Salisbury, D. F. (2024) · Clinical EEG and Neuroscience · doi:10.1177/15500594241238294 · Cited by 6

Grant Report on D-Serine Augmentation of Neuroplasticity-Based Auditory Learning in Schizophrenia †

de la Garrigue, N., Glasser, J., Sehatpour, P., Iosifescu, D. V., Dias, E. C., Carlson, M., Shope, C. B., Sobeih, T. M., Choo, T. H., Wall, M. M., et al. (2020) · Journal of Psychiatry and Brain Science · doi:10.20900/jpbs.20200018 · Cited by 6

The Role of OMICS (Genomics, Epigenetics, Transcriptomics, Proteomics and Metabolomics) in Personalized Anesthesia and Perioperative Medicine

Mohammadi‐Yeganeh, S., Bilanicz, S., & Dabbagh, A. (2020) · Springer eBooks · doi:10.1007/978-3-030-53525-4_2 · Cited by 7

Domoic Acid: Biological Effects and Health Implications

Pulido, O. M. (2014) · CRC Press eBooks · doi:10.1201/b16806-13 · Cited by 6

Neuroimaging Approaches to the Understanding of Depression and the Identification of Novel Antidepressants

Kumar, P., Harmer, C. J., & Dourish, C. T. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-386945-6.00012-3 · Cited by 6

Alcohol use in bipolar disorder: A neurobiological model to help predict susceptibility, select treatments and attenuate cortical insult

Chitty, K. M., Lagopoulos, J., Hickie, I. B., & Hermens, D. F. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.07.004 · Cited by 5

Glycine Reuptake Inhibitors in the Treatment of Negative Symptoms of Schizophrenia

Thomas, R., Baker, G. B., Dursun, S. M., Todd, K. G., Dhami, K., Chue, J., & Chue, P. S. (2014) · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology · doi:10.5455/bcp.20140918102748 · Cited by 5

Electrochemical sensor toolkit for simultaneous glutamate detection at edge of cleft and peri-soma

Liu, J., Liu, Y., Yin, D., & Tian, Y. (2025) · Cell chemical biology · doi:10.1016/j.chembiol.2025.05.002 · Cited by 4

Portraying Inhibition of Metabotropic Glutamate Receptor 5 in Fragile X Mice

Hajós, M. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.11.014 · Cited by 4

Glutamate alterations in the premature infant brain during different gestational ages with glutamate chemical exchange saturation transfer imaging: a pilot study

Ren, Q., Wan, B., Luo, X., Liu, Q., Gong, H., Li, H., Luo, M., Xu, D., Liu, P., Wang, J., et al. (2023) · European Radiology · doi:10.1007/s00330-022-09374-2 · Cited by 4

A Review of Post-Stroke Cognitive Impairment and the Potential Benefits of Stingless Bee Honey Supplementation

Ja’afar, N. L., Mustapha, M., Mohamed, M., & Hashim, S. (2024) · Malaysian Journal of Medical Sciences · doi:10.21315/mjms2024.31.3.5 · Cited by 3

Memantine for Refractory Obsessive-Compulsive Disorder: Protocol for a Pragmatic, Double-blind, Randomized, Parallel-Group, Placebo-Controlled, Monocenter Trial

Maraone, A., Trebbastoni, A., Vita, A. D., D’Antonio, F., de Lena, C., & Pasquini, M. (2023) · JMIR Research Protocols · doi:10.2196/39223 · Cited by 2

Advanced Methodology for Neurophysiological Analysis and Biomarker Development: Time–Frequency and Source-Localization Approaches

Sehatpour, P., & Javitt, D. C. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-69491-2_5 · Cited by 2

Les nouveaux cocaïnomanes : substances coupantes, prise en charge médicamenteuse et aide aux réflexes médicaux pour la prise en charge

Laborde-Rouzaud, C., Rouch, L., Chautant, F., Calvet, P., Sallerin, B. A.-M., Tiravy, J., & Cestac, P. (2014) · Le Pharmacien Hospitalier et Clinicien · doi:10.1016/j.phclin.2013.11.005 · Cited by 2

Classification issues in the developmental disorders: the case of autism and schizophrenia

Rapin, I., & Snodgrass, S. R. (2012) · Neuropsychiatry · doi:10.2217/npy.12.46 · Cited by 2

Fos-Expressing Neuronal Ensembles in Addiction Research

Hope, B. T. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812202-0.00006-3 · Cited by 2

Alcohol and Central Glutamate Activity: What Goes Up Must Come Down?

Bell, R. L., Sari, Y., & Rahman, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813125-1.00047-7 · Cited by 2

Pharmacological Role of Glutamate Transporters in Substance Use Disorders

Deehan, G. A., Waeiss, R. A., Liang, T., Rodd, Z. A., Sari, Y., Bell, R. L., & Hauser, S. R. (2022) · Springer eBooks · doi:10.1007/978-3-030-87480-3_14 · Cited by 2

Interfering with the excitatory amino acids signalling in the brain for the design of novel neuroprotective agents

Vallerini, G. P. (2013) · DSpaceUnipr (University of Parma)

Estrés Oxidativo y Esquizofrenia

Prados, A. B. (2014) · Gredos (University of Salamanca) · doi:10.14201/gredos.124073

Mediators of synaptic activity in anxiety- and depression-related behaviors

Kiselycznyk, C. (2012) · Figshare

Towards personalized medicine in psychiatry : focus on suicide

Levey, D. F. (2016) · IUScholarWorks (Indiana University) · doi:10.7912/c2zg67

Glutamate as a Neural Stress Factor in Humans and Animals

Kania, B. F., Ferdyn, K., Wojnar, T., & Lonc, G. (2019) · Journal of Behavioral and Brain Science · doi:10.4236/jbbs.2019.92002

Teaching Links between Epigenetics and Anesthesia to Anesthesia Providers

Bilanicz, S. (2018) · Digital Commons-DePaul (DePaul University)

A common molecular mechanism for cognitive deficits and craving in alcoholismPreprint

Meinhardt, M. W., Pfarr, S., Rohleder, C., Vengeliene, V., Barroso-Flores, J., Hoffmann, R., Meinhardt, M. L., Paul, E. R., Hansson, A. C., Köhr, G., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.13.200519

Bibliography: Schizophrenia

(2012) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.10.2.186

The individual vulnerability to develop compulsive adjunctive behavior is associated with the recruitment of activity-regulated cytoskeleton-associated protein (Arc) within the Locus CoeruleusPreprint

Velázquez-Sánchez, C., Mureşan, L., & Belin, D. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.13.507749

Neuropharmacology of Alcohol Addiction with Special Emphasis on Proteomic Approaches for Identification of Novel Therapeutic Targets

Mukherjee, S., & Ray, S. K. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220811092906

Effets cardioprotecteurs du glutamate contre les lésions d'ischémie-reperfusion myocardique chez la souris. Evaluation échocardiographique.

Sportouch, C. (2012) · doi:10.70675/214372c7z81e8z4f01z9ba2z8217d879ed80

Apport d'une approche translationnelle dans l'étude du lien entre flexibilité cognitive et compulsion : une étude comportementale trans-espèces

Benzina, N. (2019) · theses.fr (ABES) · doi:10.70675/95bc5546zab41z46f9z8b4dz8e7820eeb9cc

Somatostatin regulation of the stress response

Guo, H., Ali, T., & Li, S. (2026) · Brain medicine : · doi:10.61373/bm026i.0042

Role of Central Glutamatergic Neurotransmission in the Pathogenesis of Psychiatric and Behavioral Disorders

Wang, S., & Yang, T. (2005) · Drug News & Perspectives · doi:10.1358/dnp.2005.18.9.953668 · Cited by 17

Glutamatergic Dysregulation in Depression, Schizophrenia, and Addiction: Mechanisms and Therapeutic Strategies

Shi, W., & Bai, J. (2026) · Actas Españolas de Psiquiatría · doi:10.62641/aep.2307

Glutamatergic Pathways

Smith, Y. (2005) · Humana Press eBooks · doi:10.1007/978-1-59259-852-6_3 · Cited by 1

Translational medicine of the glutamate AMPA receptor

Miyazaki, T., Hiroki, A. B. E., Uchida, H., & Takahashi, T. (2021) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.97.001 · Cited by 12

Glutamate as a therapeutic target in psychiatric disorders

Javitt, D. C. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001551 · Cited by 534